Indian Stock Market Update: IT Stocks Rally, Pharma Shares Under Pressure
The Indian stock market witnessed a mixed but positive session yesterday, as benchmark indices opened higher than Wednesday’s closing levels. Early gains were supported by strong global cues and heavy buying in Information Technology (IT) stocks and PSU bank shares. However, losses in pharma, healthcare, and select consumer stocks capped the overall upside.
Investors closely tracked global market movements, quarterly earnings, and key corporate developments throughout the trading session. While IT stocks emerged as the biggest gainers, defensive sectors like pharmaceuticals faced selling pressure.
Market Opening: Positive Start to the Session
Indian equity markets began the day on a firm note, reflecting optimism carried over from the US markets. The opening trend suggested improved investor sentiment, especially in export-oriented sectors such as IT, which benefited from a slightly weaker rupee and positive earnings expectations.
As the session progressed, markets remained range-bound, with buying seen in selective stocks while profit booking was observed in others.
Sector Performance: IT and PSU Banks Lead
The IT sector was the star performer of the day. Heavyweight IT stocks such as Infosys, Tech Mahindra, TCS, HCL Technologies, and Wipro recorded strong gains. Positive quarterly results, deal wins, and improved outlook helped boost investor confidence in the sector.
PSU bank stocks also traded higher, supported by expectations of stable asset quality and steady credit growth.
On the downside, pharma and healthcare stocks declined the most. Selling pressure in stocks like Cipla weighed on the sector. Concerns over pricing pressure and profit booking after recent gains impacted pharma shares.
Global Market Cues: Mixed Signals
Global markets provided mixed signals to domestic investors.
- US markets ended higher overnight, with the Dow Jones and Nasdaq closing in the green. This supported positive sentiment in early Indian trade.
- Asian markets showed a mixed trend, as investors reacted to regional economic data and global interest rate concerns.
- European markets were mostly trading lower as of 6 pm IST, limiting the overall strength of global cues.
Despite weak European markets, Indian equities managed to hold early gains due to strong domestic stock-specific developments.
Top Gainers on NIFTY 50
IT stocks dominated the list of top gainers on the NIFTY 50 index:
- Infosys jumped 5.63% to close at Rs 1,689.80 after completing the merger of its Romanian subsidiaries, strengthening its European operations.
- Tech Mahindra surged 5.16% to Rs 1,670.50 following a 14% year-on-year rise in quarterly net profit.
- Wipro gained 2.79% to Rs 267.45 despite a drop in profits, as investors welcomed the Rs 6 per share dividend announcement.
- HCL Technologies rose 2.51% to Rs 1,698.00.
- Tata Consultancy Services (TCS) advanced 2.27% to Rs 3,206.70.
Strong buying in these stocks helped support the broader market.
Top Losers on NIFTY 50
Several stocks ended the day lower due to sector-specific weakness and profit booking:
- Eternal (Zomato) fell 3.86% to Rs 287.70.
- Jio Financial Services declined 2.86% to Rs 278.80.
- Cipla slipped 2.58% to Rs 1,397.50 amid weakness in pharma stocks.
- Hindalco dropped 2.17% to Rs 934.65 due to pressure in metal stocks.
- Asian Paints fell 2.03% to Rs 2,756.90.
Key Market News and Developments
India’s foreign exchange reserves rose by $0.39 billion to $687.2 billion for the week ended January 9. Higher forex reserves improve economic stability and support the Indian rupee during volatile global conditions.
In a major regulatory update, SEBI gave in-principle approval to NSE’s settlement application related to the unfair market access case, bringing relief to the exchange.
The Amagi Media Labs IPO received strong investor response, getting subscribed 30.22 times. Retail investors showed solid participation, with subscription at 9.31 times. The IPO has now closed for subscription.
Major Stock-Specific Updates
- Wipro reported a 7% year-on-year decline in net profit to Rs 3,119 crore for the October–December quarter and announced a dividend of Rs 6 per share.
- Polycab posted strong results, with net profit rising 36% to Rs 630 crore.
- LTIMindtree secured a Rs 3,000 crore, seven-year contract from CBDT to build an AI-powered tax analytics platform.
- BHEL began supplying traction transformers for the Vande Bharat Sleeper Train project.
- Indus Towers expanded operations by setting up step-down subsidiaries in Nigeria and Zambia.
- JSW Energy placed a major equipment order for its Salboni thermal power project.
- L&T won a large order worth Rs 2,500–5,000 crore from Petronet LNG.
- NTPC Green announced commercial operations of additional solar capacity in Gujarat.
Commodities, Currency, and Global Indices
- Gold prices slipped 0.30% to Rs 1,41,593 per 10 grams.
- Silver rose 1.58% to Rs 2,81,890 per kg.
- USD-INR strengthened to Rs 90.65 per dollar.
Globally:
- Dow Jones gained 0.60%.
- Nasdaq rose 0.25%.
Market Outlook
Yesterday’s stock market session highlighted strong interest in IT stocks driven by earnings and corporate actions, while pharma and select consumer stocks remained under pressure. With mixed global cues and steady domestic fundamentals, investors are likely to stay selective in the near term, focusing on earnings, macroeconomic data, and sector-specific trends.
Hello there! I could have sworn I’ve been to this site before but after checking through some of the post I realized it’s new to me. Anyways, I’m definitely delighted I found it and I’ll be bookmarking and checking back often!
vipjili https://www.vipjiliji.com
additional reading https://toast-wallet.net/
**herpafend**
herpafend is a natural wellness formula developed for individuals experiencing symptoms related to the herpes simplex virus.
Thi is a great article no doubt about it, i just started following you and i enjoy reading this piece. Do you post often ? we have similar post on the german best freelancer platform you can check it out if you want. Trusted source by Google.Thank you
Hello, you used to write wonderful, but the last few posts have been kinda boringK I miss your tremendous writings. Past few posts are just a little bit out of track! come on!
i enjoy reading this great article, i have shared it many times on my website and started following you, Do you post more often ?? i am the owner of https://toplinkbuildingagenturen.de/ a webdesign agency in Germany, webdesign agentur bayreuth, you can link up if you are interested. Thank you
**vivalis**
vivalis is a premium, plant-forward supplement created to help support mens daily drive, self-assurance, and steady energy.
**alpha boost**
For men, feeling strong, energized, and confident is closely tied to overall quality of life. However, with age, stress, and daily demands
**prostabliss**
prostabliss is a carefully developed dietary formula aimed at nurturing prostate vitality and improving urinary comfort.
**neurosharp**
neurosharp is a next-level brain and cognitive support formula created to help you stay clear-headed, improve recall, and maintain steady mental performance throughout the day
**aqua sculpt**
aquasculpt is a premium metabolism-support supplement thoughtfully developed to help promote efficient fat utilization and steadier daily energy.
**nervecalm**
nervecalm is a high-quality nutritional supplement crafted to promote nerve wellness, ease chronic discomfort, and boost everyday vitality.
**ignitra**
ignitra is a thoughtfully formulated, plant-based dietary supplement designed to support metabolic health, balanced weight management, steady daily energy, and healthy blood sugar levels as part of a holistic wellness approach.
**gluco tonic**
gluco tonic is an expertly formulated dietary supplement designed to help maintain balanced blood sugar levels naturally.
**back biome**
back biome is a naturally crafted, research-backed daily supplement formulated to gently relieve back tension and soothe sciatic discomfort.